Q2 EPS Estimate for Cardinal Health Lifted by Analyst

Cardinal Health, Inc. (NYSE:CAH) – Research analysts at Leerink Partnrs raised their Q2 2026 earnings estimates for shares of Cardinal Health in a research note issued on Thursday, October 30th. Leerink Partnrs analyst M. Cherny now forecasts that the company will post earnings per share of $2.25 for the quarter, up from their prior forecast of $2.24. The consensus estimate for Cardinal Health’s current full-year earnings is $7.95 per share. Leerink Partnrs also issued estimates for Cardinal Health’s Q3 2026 earnings at $2.74 EPS, Q4 2026 earnings at $2.29 EPS, FY2026 earnings at $9.84 EPS, FY2027 earnings at $11.08 EPS, FY2028 earnings at $12.42 EPS and FY2029 earnings at $14.00 EPS.

Cardinal Health (NYSE:CAH) last issued its earnings results on Thursday, October 30th. The company reported $2.55 EPS for the quarter, topping analysts’ consensus estimates of $2.22 by $0.33. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The company had revenue of $64.01 billion for the quarter, compared to analysts’ expectations of $59.41 billion. During the same quarter last year, the company earned $1.88 EPS. The firm’s revenue was up 22.4% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS.

Other equities analysts have also recently issued research reports about the stock. Mizuho set a $210.00 price target on shares of Cardinal Health in a research report on Monday. Morgan Stanley reiterated an “overweight” rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Leerink Partners boosted their price target on shares of Cardinal Health from $187.00 to $211.00 in a research report on Friday. Evercore ISI boosted their price objective on shares of Cardinal Health from $190.00 to $220.00 and gave the stock an “outperform” rating in a research note on Friday. Finally, Weiss Ratings reissued a “buy (b)” rating on shares of Cardinal Health in a research note on Wednesday, October 8th. Eleven investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, Cardinal Health has a consensus rating of “Moderate Buy” and a consensus price target of $200.54.

Cardinal Health Price Performance

Shares of NYSE CAH opened at $190.22 on Monday. Cardinal Health has a 1 year low of $110.63 and a 1 year high of $197.67. The company’s 50-day moving average is $156.05 and its 200 day moving average is $155.04. The stock has a market capitalization of $45.19 billion, a P/E ratio of 29.49, a P/E/G ratio of 1.39 and a beta of 0.71.

Cardinal Health Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st were paid a $0.5107 dividend. This represents a $2.04 annualized dividend and a dividend yield of 1.1%. The ex-dividend date was Wednesday, October 1st. Cardinal Health’s dividend payout ratio is currently 30.77%.

Insider Transactions at Cardinal Health

In other news, insider Jessica L. Mayer sold 38,078 shares of the company’s stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total value of $5,666,767.96. Following the transaction, the insider owned 48,457 shares in the company, valued at approximately $7,211,370.74. This represents a 44.00% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Jason M. Hollar sold 107,705 shares of the company’s stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $148.90, for a total transaction of $16,037,274.50. Following the completion of the transaction, the chief executive officer owned 235,901 shares in the company, valued at approximately $35,125,658.90. This represents a 31.35% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 271,676 shares of company stock valued at $40,489,525. 0.12% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in CAH. Latitude Advisors LLC lifted its holdings in shares of Cardinal Health by 2.1% during the 3rd quarter. Latitude Advisors LLC now owns 2,598 shares of the company’s stock valued at $408,000 after buying an additional 53 shares during the period. MassMutual Private Wealth & Trust FSB lifted its holdings in shares of Cardinal Health by 3.6% during the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 1,767 shares of the company’s stock valued at $297,000 after buying an additional 62 shares during the period. WESPAC Advisors LLC lifted its holdings in shares of Cardinal Health by 1.0% during the 3rd quarter. WESPAC Advisors LLC now owns 6,644 shares of the company’s stock valued at $1,043,000 after buying an additional 63 shares during the period. Kathmere Capital Management LLC lifted its holdings in shares of Cardinal Health by 1.6% during the 3rd quarter. Kathmere Capital Management LLC now owns 4,091 shares of the company’s stock valued at $642,000 after buying an additional 65 shares during the period. Finally, Empirical Financial Services LLC d.b.a. Empirical Wealth Management lifted its holdings in shares of Cardinal Health by 0.4% during the 2nd quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 17,805 shares of the company’s stock valued at $2,991,000 after buying an additional 69 shares during the period. Institutional investors own 87.17% of the company’s stock.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.